Genzyme 3Q Revenues: $808.6 million (+14%) 3Q Earnings: $16 million (earnings were $115.7 million 3Q2005)* YTD Revenues: $2.3 billion (+16%) YTD Earnings: $251 million (-25%) Comments: Myozyme was a significant new contributor in the quarter with the first full quarter of sales $20.4 million. Fabrazyme, Aldurazyme, Cerezyme and Renagel also contributed to revenue growth in the quarter. Sales of Fabrazyme rose 18% to $93.2 million. Sales of Aldurazyme rose 24% to $25 million. S...